Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heterologous immunity revisited.

I A Clark1

  • 1Division of Biochemistry and Molecular Biology, School of Life Sciences, Australian National University, Canberra, ACT. ian.clark@anu.edu.au

Parasitology
|July 10, 2001
PubMed
Summary

Heterologous immunity protects against diverse invaders by utilizing soluble mediators like pro-inflammatory cytokines and nitric oxide. Understanding these mechanisms is crucial for host defense and vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.

Journal of Alzheimer's disease : JAD·2021
Same author

Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective - a Commentary.

Expert review of neurotherapeutics·2019
Same author

Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases.

British journal of pharmacology·2018
Same author

Intrusive memories to traumatic footage: the neural basis of their encoding and involuntary recall.

Psychological medicine·2015
Same author

Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease.

British journal of pharmacology·2015
Same author

Inflammatory fatigue and sickness behaviour - lessons for the diagnosis and management of chronic fatigue syndrome.

Journal of affective disorders·2012

Area of Science:

  • Immunology
  • Microbiology
  • Host-Pathogen Interactions

Background:

  • Heterologous immunity describes cross-protection between different types of invading organisms.
  • Initial theories focused on phagocytosis enhancement, but evidence suggested soluble mediators were involved.
  • Observations against intraerythrocytic protozoa highlighted the need for non-phagocytic mechanisms.

Purpose of the Study:

  • To review the logical progression of understanding heterologous immunity.
  • To explore the role of soluble mediators, specifically pro-inflammatory cytokines and nitric oxide.
  • To discuss the implications of these mediators for host defense and potential self-harm.

Main Methods:

  • Literature review and synthesis of existing research on heterologous immunity.
  • Analysis of historical observations and their impact on immunological thought.
  • Examination of the dual role of inflammatory mediators in host defense and pathology.

Main Results:

  • The understanding of heterologous immunity evolved from phagocytosis to soluble mediators.
  • Pro-inflammatory cytokines and nitric oxide were identified as key mediators.
  • These mediators can be beneficial for host defense but also cause self-harm if overproduced.

Conclusions:

  • Heterologous immunity involves a complex interplay of soluble mediators.
  • The dual nature of these mediators (beneficial and harmful) is a critical aspect.
  • Lessons from heterologous immunity inform broader fields, including vaccine design.

Related Experiment Videos